WELLINGTON MANAGEMENT GROUP LLP 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-10 10:25 am Sale | 2024-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE | WELLINGTON MANAGEMENT GROUP LLP | 2,457,543 2.700% | -1,957,486 (-44.34%) | Filing |
| 2024-02-08 10:18 am Sale | 2023-12-29 | 13G | Ultragenyx Pharmaceutical Inc. RARE | WELLINGTON MANAGEMENT GROUP LLP | 4,415,029 5.380% | -787,655 (-15.14%) | Filing |
| 2023-02-06 2:58 pm Purchase | 2022-12-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE | WELLINGTON MANAGEMENT GROUP LLP | 5,202,684 7.420% | 3,918,574 (+305.16%) | Filing |